Rhodium(III)-Catalyzed C-H Activation: Ligand-Controlled Regioselective Synthesis of 4-Methyl-Substituted Dihydroisoquinolones

被引:29
作者
Barber, Joyann S. [1 ,2 ]
Scales, Stephanie [1 ]
Tran-Dube, Michelle [1 ]
Wang, Fen [1 ]
Sach, Neal W. [1 ]
Bernier, Louise [1 ]
Collins, Michael R. [1 ]
Zhu, JinJiang [1 ]
McAlpine, Indrawan J. [1 ]
Patman, Ryan L. [1 ]
机构
[1] Pfizer Oncol Med Chem, 10770 Sci Ctr Dr, San Diego, CA 92121 USA
[2] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA
关键词
LIPOPHILIC EFFICIENCY; BOND FORMATION; DESIGN; DISCOVERY; CHEMISTRY;
D O I
10.1021/acs.orglett.9b02029
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Rh-catalyzed C-H functionalization of O-pivaloyl benzhydroxamic acids with propene gas provides access to 4-methyl-substituted dihydroisoquinolones. Good to excellent levels of regioselectivity are achieved using [(CpRhCl2)-Rh-t](2) as a precatalyst under optimized conditions. Thorough examination of aryl/heteroaryl O-pivaloyl hydroxamic acid substrates, ligand effects on C-H site selectivity, alkene scope, and demonstration of scale are discussed within.
引用
收藏
页码:5689 / 5693
页数:5
相关论文
共 43 条
[1]   The Methylation Effect in Medicinal Chemistry [J].
Barreiro, Eliezer J. ;
Kuemmerle, Arthur E. ;
Fraga, Carlos A. M. .
CHEMICAL REVIEWS, 2011, 111 (09) :5215-5246
[2]  
Buchstaller H.-P., 2017, Patent, Patent No. [WO2017020981, 2017020981]
[3]   2-(QUINUCLIDIN-3-YL)PYRIDO[4,3-B]INDOL-1-ONES AND ISOQUINOLIN-1-ONES - POTENT CONFORMATIONALLY RESTRICTED 5-HT(3) RECEPTOR ANTAGONISTS [J].
CLARK, RD ;
MILLER, AB ;
BERGER, J ;
REPKE, DB ;
WEINHARDT, KK ;
KOWALCZYK, BA ;
EGLEN, RM ;
BONHAUS, DW ;
LEE, CH ;
MICHEL, AD ;
SMITH, WL ;
WONG, EHF .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (18) :2645-2657
[4]   Rhodium-Catalyzed C-C Bond Formation via Heteroatom-Directed C-H Bond Activation [J].
Colby, Denise A. ;
Bergman, Robert G. ;
Ellman, Jonathan A. .
CHEMICAL REVIEWS, 2010, 110 (02) :624-655
[5]   Rhodium(III)-Catalyzed Intramolecular Hydroarylation, Amidoarylation, and Heck-type Reaction: Three Distinct Pathways Determined by an Amide Directing Group [J].
Davis, Tyler A. ;
Hyster, Todd K. ;
Rovis, Tomislav .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2013, 52 (52) :14181-14185
[6]   Transition-Metal-Catalyzed C-H Alkylation Using Alkenes [J].
Dong, Zhe ;
Ren, Zhi ;
Thompson, Samuel J. ;
Xu, Yan ;
Dong, Guangbin .
CHEMICAL REVIEWS, 2017, 117 (13) :9333-9403
[7]   Role of Physicochemical Properties and Ligand Lipophilicity Efficiency in Addressing Drug Safety Risks [J].
Edwards, Martin P. ;
Price, David A. .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45, 2010, 45 :381-391
[8]  
Freeman-Cook KD, 2013, FUTURE MED CHEM, V5, P113, DOI [10.4155/FMC.12.208, 10.4155/fmc.12.208]
[9]   GPR103 Antagonists Demonstrating Anorexigenic Activity in Vivo: Design and Development of Pyrrolo[2,3-c]pyridines That Mimic the C-Terminal Arg-Phe Motif of QRFP26 [J].
Georgsson, Jennie ;
Bergstrom, Fredrik ;
Nordqvist, Anneli ;
Watson, Martin J. ;
Blundell, Charles D. ;
Johansson, Magnus J. ;
Petersson, Annika U. ;
Yuan, Zhong-Qing ;
Zhou, Yiqun ;
Kristensson, Lisbeth ;
Kakol-Palm, Dorota ;
Tyrchan, Christian ;
Wellner, Eric ;
Bauer, Udo ;
Brodin, Peter ;
Henriksson, Anette Svensson .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (14) :5935-5948
[10]   Rhodium(III)-Catalyzed Heterocycle Synthesis Using an Internal Oxidant: Improved Reactivity and Mechanistic Studies [J].
Guimond, Nicolas ;
Gorelsky, Serge I. ;
Fagnou, Keith .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (16) :6449-6457